CELSIUS®’ Newest Product Launch, Celsius Heat™, Selected As One Of Beverage Industry’s 2017 Innovations Of The Year

CELSIUS®’ trainer-grade pre-workout leads the pack in energy drink innovation

Celsius Holdings, Inc. (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today announced that its new trainer-grade line, CELSIUS HEAT™, was selected as one of Beverage Industry’s Innovations of the Year in the energy drink category. The editors of Beverage Industry, the leading trade publication written for executives of the beverage processing industry, evaluated new beverage launches released throughout 2017. As a result, the editors identified the five beverages that are driving innovation based on their unique characteristics and ability to fill a need within the beverage market. In CELSIUS HEAT™’s case, the demand was for a proven, trainer-grade pre-workout drink that provides long-lasting energy. The 2017 Innovations of the Year will be featured in Beverage Industry’s December issue.

“We are honored that Beverage Industry recognizes the innovation that sets CELSIUS HEAT™ apart from any other fitness drink, namely that it’s a pre-workout option that not only tastes amazing, but is clinically proven to perform. We added HEAT™ to our portfolio to satisfy gym-goers looking for a zero-sugar energy solution and to ride the wave of the popularity of carbonation,” says Vanessa Walker, Executive Vice President of Sales and Marketing. “We are confident that HEAT™ will continue to drive sales for CELSIUS® and expand our position as the leader in the fitness drink market.”

CELSIUS HEAT™ is a dietary supplement that contains the proprietary thermogenic formula, MetaPlus®, also found in CELSIUS® Original and Natural line extensions, which accelerates metabolism, burns fat and boosts energy when combined with exercise. HEAT™’s 16oz. carbonated can contains 300mg of caffeine and 2,000mg of L-Citrulline. It is designed to serve as a supercharged version of the original CELSIUS® formula, ideal for trainers, body builders, military personnel and endurance athletes looking to optimize their training results.

“This honorable recognition in the Beverage Industry demonstrates our products are leading innovation in the category. HEAT™ is a great tasting proven addition to the CELSIUS® portfolio and further expands the recognition of the award winning CELSIUS® brand,” said Interim CEO and CFO John Fieldly. “Our latest SPINS data shows a 40.6 percent year-over-year increase for our CELSIUS® product portfolio in the MULO channel, which validates our positioning as a healthy, functional fitness drink that resonates with consumers (SPINS, MULO 52wks ending 11.05.17). We are confident that CELSIUS HEAT™ will drive those sales figures even higher.”

Celsius Holdings launched CELSIUS HEAT™ in the fitness channel nationwide early in the second quarter, 2017, featuring three flavors: Inferno Punch, Blueberry Pomegranate and Cherry Lime. In September, we introduced those three flavors to the convenience store channel and also broadened the line with the addition of Strawberry Dragonfruit and Tangerine Grapefruit flavors to the fitness channel.

CELSIUS®’ PROVEN campaign surrounding HEAT™ features platinum recording artist, Flo Rida. Flo Rida personifies the brand and is the newly appointed CELSIUS HEAT™ Elite, Chief Ambassador, who will lead the “HEAT™ Elite,” a hand-picked group of individuals who excel at fitness performance and are PROVEN to excel in their chosen field. He relies on CELSIUS HEAT™ to optimize his training results and give him the healthy energy he needs to rock grueling concerts and workouts. Flo Rida puts a premium on health and fitness and believes in the delicious, thermogenic pre-workout drink. The PROVEN campaign is currently showcased on billboards featuring Flo Rida throughout Florida and Texas.

 About Celsius Holdings, Inc.

Celsius Holdings, Inc. (Nasdaq: CELH), founded in April, 2004, is a global company, with a proprietary, clinically proven formula for its brand CELSIUS®. Celsius Holdings, Inc. has a corporate mission to become the global leader of a branded portfolio which is proprietary, clinically proven, or innovative in its category and offers significant health benefits. CELSIUS®’ original line comes in seven delicious sparkling and non-carbonated flavors in sleek 12oz cans and is also available in single-serve powdered packets. CELSIUS®’ new natural line is available in six refreshing flavors: three sparkling and three non-carbonated. This line is naturally caffeinated and naturally sweetened.

New to the portfolio, CELSIUS HEAT™, (www.CELSIUSHEAT.com) a trainer-grade version of the proprietary blend, offers additional caffeine as well as L-Citrulline, a proven vasodilator. CELSIUS HEAT™ is sold in 16oz cans and is available in five carbonated flavors: Inferno Punch, Cherry Lime, Blueberry Pomegranate, Strawberry Dragonfruit and Tangerine Grapefruit. CELSIUS HEAT™ targets professional trainers, endurance & competitive athletes, those who focus on defined, physical results and the military, versus the flagship line which comes in a smaller package and appeals to the masses as an active lifestyle brand.

CELSIUS® has zero sugar, no preservatives, no aspartame, no high fructose corn syrup, and is non-GMO, with no artificial flavors or colors. The CELSIUS® line of products is kosher and vegan certified, soy, gluten, and sugar-free and contains very little sodium. CELSIUS® is sold nationally at fitness clubs, 7-Eleven stores, Sprouts, The Fresh Market and key regional retailers such as HEB, Publix, Winn-Dixie, Harris Teeter, Shaw’s and others. The first university study of the science underlying CELSIUS® products was conducted in 2005 and additional studies from the University of Oklahoma were conducted over the next five years. All studies were published in peer-reviewed journals and validate the unique benefits that CELSIUS® provides. For more information, please visit www.celsiusholdingsinc.com.

Rose Parade Float To Honor 29-Year Old Tissue Donor From Newark

Local Resident One of Four New Jerseyans Recognized on the

2018 Rose Parade Donate Life Float

At the January 2018 Rose Bowl Parade, four New Jersey families will be in Pasadena to see the Donate Life Float in the Tournament of Roses Parade. One of these families will be the Garcia family from Newark, NJ. Making its 15th appearance in 2018, the float serves as a memorial to organ and tissue donors and a platform for donor families, living donors and transplant recipients to inspire the world to save and heal those in need through the gift of life.

With support from Donate Life America and other affiliate organizations, NJ Sharing Network, the family and friends of Ezequiel and Iris Garcia will gather in The Learning Center at Clara Maass Medical Center, One Clara Maass Drive in Belleville on Thursday, November 30th at 6:00 PM to finish a floragraph – a portrait that is made from natural materials, such as flowers and seeds in the likeness of organ and tissue donor Reinaldo Garcia, who passed away suddenly in 2011.  Once the floragraph is complete, it will then travel to Pasadena to be placed on the Donate Life Float.

Clara Maass Medical Center is a hospital partner of NJ Sharing Network and where Ezequiel and Iris return to share their son’s story with staff.

García’s floragraph is sponsored by Bridge to Life Ltd, whose mission is to improve organ transplants through licensing and developing new preservation solutions and technologies and providing the highest quality of service to organ procurement organizations and transplant centers.

“It is an honor to partner with Bridge to Life as the Garcia family travels to California to celebrate Reinaldo and the lives he touched,” said Joe Roth, President and CEO, NJ Sharing Network. “The Donate Life Float is a remarkable tribute to the power of organ and tissue donation.”

García, who lived in Newark, NJ became a tissue donor at the age of 29. Growing up, García was a very healthy and active boy, who, early in life, demonstrated a high degree of intelligence, curiosity and ability to play sports. He finished his undergraduate degree in Education and became a Physical Education teacher at a local High School in Newark. He was beginning his sixth year as a teacher when he passed away in September 2011. García had a very pleasant personality and was passionate about everything in life. He loved to coach younger athletes and volunteer for all kind of events and activities. According to his family, offering Reinaldo’s tissue for donation is the most important decision they have ever made. His father, Ezequiel García, and his mother, Iris, are both volunteers of NJ Sharing Network and are passionate advocates of the organization’s mission. Ezequiel recently joined the Foundation Board of Trustees at NJ Sharing Network.

To date, there are over 120,000 people waiting for a transplant and 22 die each day while waiting for a transplant, but one donor can save eight lives and one tissue donor can enhance the lives of over 75 people.  In New Jersey, there are over 4,000 people on the waiting list and one person dies every three days waiting.

New Jersey residents can help save lives by registering as organ and tissue donors at www.NJSharingNetwork.org, talking about it with their families and friends and joining NJ Sharing Network at its next event.

About NJ Sharing Network

NJ Sharing Network saves lives through organ and tissue donation. Located in New Providence, the organization recovers organs and tissue and belongs to a national network that helps the 120,000 people waiting for a transplant.  In 2016, more lives were saved than ever before. Thanks to the selflessness of New Jersey organ donors and their families who said yes to donation last year, 613 people are alive today. This year, the organization is celebrating 30 years of saving lives. To learn more, get involved and register as an organ and tissue donor, visit www.NJSharingNetwork.org.

About Clara Maass Medical Center
Located in Belleville, NJ, Clara Maass Medical Center, an RWJBarnabas Health facility, provides a complete continuum of care to residents of northern New Jersey. Clara Maass recently completed state-of-the-art campus expansion project featuring a new four-story 87,000 square foot building with a private, 32-bed Intensive Care Unit, new Main Entrance and Lobby, Retail Pharmacy, Patient Registration Area and designated new space to accommodate our future Emergency Department expansion. Clara Maass’ services include: The Cancer Center, Center for Breast Health and Disease Management, Radiation Oncology, Infusion Therapy, Cardiac Services Elective and Emergency Angioplasty and Cardiac Rehabilitation, The Pain Management Center, The Joint & Spine Institute, a Vascular Lab, The Vein Center, The Wound Center, The Center for Sleep Disorders, The Bariatric Surgery Center, Rehabilitation; Therapy Services which includes, physical therapy, occupational therapy and speech therapy, The Eye Surgery Center, Maternity Services and Parent Education, Pediatrics, Center of Excellence for Latino Health, and the Health and Wellness Center. Clara Maass has been recognized nine Grade ‘A’ scores for patient safety and quality by The Leapfrog Group. It is listed by the American Hospital Association as one of Healthcare’s Most Wired hospitals. In 2016-17 Clara Maass has received the Healthgrades Obstetrics and Gynecology Excellence Award and the Labor and Delivery Excellence Award. Clara Maass received Disease Specific Care Certification from the Joint Commission for Acute Coronary Syndrome (ACS), Congestive Heart Failure, Hip Replacement, Knee Replacement, Cardiac Rehabilitation and Advanced Certification in Palliative Care. Clara Maass earned Clara Maass’ steadfast commitment to improve the health and well-being of the communities it serves is exemplified through award winning programs including the nationally recognized HELP Volunteer program, recipient of the American Hospital Association 2017 HAVE Award, and the Wellness Assessment Van for Elders (WAVE) which was recognized as the New Jersey Hospital Association’s 2017 HRET Community Outreach Award. For a physician referral or more information about Clara Maass, call 1-888-724-7123 or visit www.rwjbh.org/claramaass.

Strata Company Launches SmartMove Offering At 2017 SHSMD Connections

Connects Healthcare Providers with New Residents through Advanced Multi-Touch Marketing Methodology and Digital Enhancements

Strata Company, a leading Pennsylvania-based marketing services and technology solutions firm, is introducing a new and enhanced version of its new mover marketing offering. The SmartMove program is being officially released here at the SHSMD 2017 conference. It is a next-gen, multichannel approach to new mover marketing. It builds on Strata’s long-established success in reaching and engaging new residents in clients’ market areas.

Strata Company’s SmartMove program enhances traditional offerings with digital components such as automated and segmented email marketing campaigns and a proprietary, personalized online response dashboard. The enhancements add value and increase campaign effectiveness to more efficiently meet client goals, accelerate healthcare providers’ ability to connect with new residents and keep them engaged over time.

“SmartMove was developed to help hospitals and health systems keep pace with the rapidly changing way in which consumers search for and select a healthcare provider,” said Mark Frisina, VP of Strata Company. “With SmartMove, healthcare marketers get their foot in the door to establish a connection before their competition. The ongoing program allows providers to stay top of mind as new residents get established, create new ‘buying’ behaviors and develop preferences that will influence future decisions.”

SmartMove helps healthcare marketers target the right audiences, issue direct mail campaigns to greet new residents upon move-in, keep respondents engaged with relevant information – via drip email campaigns – and provide in-depth reporting to measure and improve program performance. SmartMove’s direct marketing strategy utilizes tactile and digital touchpoints – a critical driver in successfully connecting with the modern consumer.

“By combining the power of multiple channels, and then gaining real-time, personalized insights via our custom technology capabilities, we help healthcare marketers stay ahead of the curve,” Frisina notes. “SmartMove gives them another tool in their modern marketing arsenal through which they can capture attention, build affinity and drive referrals. For healthcare marketers looking to cut through the noise, counter the competition and gain valuable insights into what their target audience is looking for, the latest in new mover marketing can get them the results and return they’re looking for.”

Visit Booth #402 at SHSMD 2017 for more information about Strata Company and the SmartMove offering, or visit http://info.gostrata.com/make-the-smart-move.

About Strata Company

Established in 1993, Strata Company provides marketing, communications and technology solutions that enable companies to increase efficiency, effectiveness and revenue. By leveraging industry expertise and relevant technologies, the firm delivers solutions that resolve process, execution and logistics challenges. Its specialties include cloud-based marketing and communications management solutions, data-driven marketing and full-service execution services. Learn more at www.gostrata.com.

Pediatricians Choose Temporal Artery Thermometer As Top Pick Among Temperature Taking Methods

“Exergen Temporal Artery Thermometer is fast, reliable and accurate “

For the eighth year in a row, pediatricians ranked the temporal artery thermometer (TAT) as the number one overall preferred method of thermometry, according to a recent survey. Of the 216 survey respondents, more than half (54 percent) of pediatricians chose temporal artery as their preferred method of thermometry based on ease of use. In addition, 41 percent cited temporal artery as the overall preferred method of thermometry compared to ear, rectal, oral and axillary, ranking the TAT number one in this category.

This new study demonstrates how the Exergen TemporalScanner remains, over time, the most trusted temporal artery thermometer brand and one of the top overall thermometer brands used and recommended in pediatrician offices. Survey findings show 39 percent of pediatricians use Exergen Temporal Artery Thermometer in their offices, and nearly 75 percent of those pediatricians recommend the Exergen brand to their patients and colleagues. The survey results also indicate that pediatricians use the Exergen TAT for a range of patient ages.

“Every year, these study results confirm that the Exergen TAT is the number one preferred by pediatricians for a variety of reasons, which include ease of use and noninvasive properties,” said Dr. Francesco Pompei, CEO of Exergen Corporation. “’More and more pediatricians trust and rely on the TAT, whose accuracy and versatility is backed by more than 70 clinical studies. It offers great versatility, as well, and pediatricians are comfortable using our thermometer on all ranges of patient ages and medical conditions.”

The survey captured pediatricians’ commentary about temporal artery thermometry, specifically strengths of the Exergen TAT. One physician respondent noted, “I have used the Exergen [TAT] for many years – it is easy, quick and gives me the information I need.” Another respondent stated, “Temporal Artery is easiest to use – digital, oral and rectal [are] more time consuming and require patient cooperation.”

The survey was conducted by Pragmatic Research, Inc. and pediatricians were not told that it was sponsored by Exergen. The results were consistent with other independent research involving nurses and other healthcare professionals in various clinical settings.

ABOUT EXERGEN CORPORATION

Exergen manufactures and markets two types of the TemporalScanner thermometer: a professional version for doctors’ offices and hospitals, and a consumer model sold in major retailers nationwide. Nearly two billion temperatures are taken each year with the TemporalScanner. It is used in thousands of hospitals, clinics and pediatricians’ offices across the country, as well as in millions of homes. It is the #1 preference of pediatricians, #1 preference of nurses in the US, and #1 selling retail thermometer. The Exergen TemporalScanner’s performance is supported by more than 70 peer-reviewed published studies covering all ages from preterm infants to geriatrics and all care areas from hospitals to homes. For additional information, visit www.exergen.com.

 

Feintuch Communications and Rosica Communications Form Joint Venture

New York City-based Feintuch Communications and Fair Lawn, New Jersey-based Rosica Communications have created a joint venture to offer complementary services to each other’s clients, as well as prospects.

Feintuch Communications, founded in 2009 by tech industry veteran and former journalist Henry Feintuch, is a B2B PR and marketing agency specializing in technology, financial services/fintech, cleantech/clean energy, manufacturing tech, adtech/media and professional services. Feintuch is a past chair of the technology section of the Public Relations Society of America (PRSA) and a board member and past president of PRSA-NY. He also serves as chief financial officer of the Public Relations World Alliance, a global network of independent PR firms.

Rosica Communications, founded in 1980, is a full-service communications firm offering traditional media relations, as well as the latest online marketing and social media offerings. Specialty areas include consumer and home products, healthcare, food and beverage, non-profit/association, animal health/pet products, education and B2B and professional services. Agency President Chris Rosica is the author of The Authentic Brand and The Business of Cause Marketing. In 2009, he co-founded Interact Marketing, LLC, a full-service interactive agency. He continues to serve as the firm’s chairman.

“Chris and I were introduced to each other a few years ago and we began an informal collaboration to offer each other’s clients additional services on an ad-hoc basis,” said Feintuch. “Rosica has in-depth expertise in many segments not currently offered by our firm and its team is top notch.”

“Our firms share a similar work ethic and are oriented towards delivering business results to achieve our clients’ objectives,” said Rosica. “Together, we offer a broad range of consumer, business-to-business, tech and corporate services to clients nationwide from our offices in New Jersey and New York. Our collaboration increases our bench strength and ability to deliver world-class service.”

 About Feintuch Communications

Feintuch Communications (www.feintuchcommunications.com), based in New York City, is an award-winning strategic relations firm offering clients an integrated blend of public relations, analyst relations, advertising/marketing, financial and investor relations and other services to meet their business objectives.  A founding partner of PR World Alliance (www.PRWorldAlliance.com), the firm specializes in B-to-B and B-to-C programs with a focus in technology, financial services, advertising and media and energy/clean tech. Feintuch Communications prides itself on its strong service ethic, senior counsel and hands-on support.

About Rosica Communications

Established in 1980, Rosica Communications specializes in media relations, content development, crisis communications, cause marketing, direct marketing and social media. The firm’s national B2B and B2C clientele encompasses companies in the healthcare, technology, food, beauty, professional services and animal health/pet goods industries. The agency’s differentiators include: Sales Smart PRsm, which repurposes media coverage to augment sales; content development and syndication to bolster SEO and online reputations; cultivation and media training of key opinion leaders and influencers; and the firm’s ability to integrate online and traditional PR and marketing.

For further information: Henry Feintuch, Feintuch Communications, 212.808.4901, henry@feintuchpr.com; Chris Rosica, Rosica Communications, 201.843.5600, chris@rosica.com

Bridor’s Popular Savory Bistro Line Now Made With Cage Free Eggs

Bridor, the leader in bringing high quality, European style croissants, pastries and breads to the U.S. foodservice and retail markets recently announced that its savory Bistro items are now made with cage-free eggs. The United States egg industry is rapidly changing as major restaurants, quick service chains, retailers and manufacturers are making the shift to cage-free eggs. As part of the company’s commitment to meeting consumer expectations, Bridor plans to use cage-free eggs in all of its products by 2020.

Bridor’s savory Bistros are a unique savory pastry available in Margherita, Egg, Leek and Parmesan, Tomato and Olive, and Spinach and Feta. The five Bistros by Bridor are delivered pre egg-washed, pre-proofed and ready to bake and under 350 calories. They contain fresh ingredients, no artificial flavors and no preservatives. The Bistro is a convenient small meal, appetizer or snack, and consumers say they enjoy it as an alternative to pizza and quiche.

“Our savory Bistros are the result of innovation to fit today’s consumer needs, and trade and foodservice operators have embraced our Bistro items since we introduced the line,” said Olivier Morel, Senior VP, Sales and Marketing, Bridor. “By making the shift towards cage-free eggs, our customers will have even greater satisfaction that our products are made with the finest high-quality ingredients.”

Bridor also recently announced its Clean Label Program, which bans the use of over 150 ingredients, including artificial colors and flavors, preservatives, artificial sweeteners, bleached flour, high fructose corn syrup and hydrogenated or partially hydrogenated fats. The Clean Label line encompasses over 200 products, a figure that could rise to 300 by the end of 2017.

ABOUT BRIDOR

Bridor USA Inc. is a subsidiary of Bridor Inc., which has specialized in bringing the highest quality European style bread and Viennese pastry to the North American market for 30 years. Bridor manufactures breads and pastries that reflect its European heritage while satisfying North American preferences.  For more information visit Bridor.com/en.

New Independent Studies Show Exergen Reduces Hospital Costs by 90% Compared To Other Thermometers

“Yielded clear-cut cost savings that increased exponentially with increasing duration of use and increasing bed numbers per device.”

Two new studies from Postgraduate Medical Journal indicate that when used throughout a hospital, Exergen TemporalScanners deliver substantial cost savings while providing accuracy and ease of use, as supported by more than 70 peer-reviewed published studies for all ages and clinical settings.

The first study, “Cost minimisation analysis of thermometry in two different hospital systems[1],” was conducted at University Hospital Centre Zagreb (UHCZ) and University of Michigan Hospitals (UMH), each of which used the Exergen TAT-5000 to evaluate cost savings. Results dramatically favored TAT over tympanic thermometry at UHCZ, where the cost of consumables per measurement would be more than 10 times cheaper for TAT, leading to considerable budget savings within a year of hospital-wide implementation. The UMH study concluded that routine use of Exergen TAT-5000 would lead to cost savings over three years at UMH.

The second study, “Minimising the costs of temperature monitoring in hospitals[2],” revealed that Exergen TAT-5000 savings exceeded $1.7 million when there were 10 beds per device used for five years. In addition, the study indicated that other forms of thermometry such as oral, axillary and rectal are not favored by hospital staff due to numerous factors including time commitment needed from the healthcare provider, patient discomfort and the potential to wake a sleeping patient.

“We appreciate how cost is a critical consideration in hospital purchasing today, and we are committed to providing a product, the Exergen TAT-5000, that delivers significant cost savings,” said Francesco Pompei, Ph.D., CEO of Exergen Corporation. “This has wide implications for maximizing savings, as our thermometer is the single standard of uniform care in hospitals nationwide, giving more healthcare professionals and patients access to its many benefits.”

The above, along with other independent studies, confirm suitability among all patient groups, including premature infants, adults and geriatrics, and under all medical conditions. For a complete list of studies visit www.exergen.com/c .

ABOUT EXERGEN CORPORATION

Exergen manufactures and markets two types of the TemporalScanner thermometer: a professional version for doctors’ offices and hospitals, and a consumer model sold in major retailers nationwide. Nearly two billion temperatures are taken each year with the TemporalScanner. It is used in thousands of hospitals, clinics and pediatricians’ offices across the country, as well as in millions of homes. It is the #1 preference of pediatricians, #1 preference of nurses in the US, and #1 selling retail thermometer. The Exergen TemporalScanner’s performance is supported by more than 70 peer-reviewed published studies covering all ages from preterm infants to geriatrics and all care areas from hospitals to homes. For additional information, visit www.exergen.com.

 

[1] Hayes K, Shepard A, Cesarec A, et al. Cost minimisation analysis of thermometry in two different hospital systems. Postgrad Med J Published Online First: 18 January 2017, doi:10.1136/postgradmedj-2016-134630

[2] Kumana C. Minimising the costs of temperature monitoring in hospitals. Postgrad Med J Published Online First: 1 February 2017 doi:10.1136/postgradmedj-2017-134795

 

Indigo Sleep’s Breakthrough Modular Mattress Delivers Comfort You Can Customize

Patented Design Unlocks Value Inside the Mattress, Saving Money and Easing Stress on the Planet

Newly-launched Indigo Sleep is upending the mattress industry with a breakthrough mattress that literally opens up a new way of sleeping. At the heart of its Comfort Always® mattress is a modular design that lets you pop off the mattress cover and rotate or flip it to meet your comfort preferences, whether firm or soft, giving you two mattress “feels” for the price of one. It even offers a cooling temperature option for one or both sleepers. The renewable aspect refers to the patented design, which was grounded in intensive research. When a section of the mattress becomes worn, you can simply replace that part at a fraction of the price of a new mattress. This can extend the life of the original mattress indefinitely and significantly reduce the number of used mattresses that are being thrown away and damaging the environment.

To provide added value to consumers, Indigo bypassed the costly bricks and mortar business model and is selling its mattresses via e-commerce at indigosleep.com.

The company was founded by tech and startup veterans David Funk and Gene DeRose who are determined to shake up an industry in urgent need of a wake up call. They saw traditional mattresses as being overpriced, potentially hazardous to your health because many contain toxic chemicals, and harmful to the environment. In forming Indigo Sleep, they are making that model obsolete and giving people a new way to sleep. In testing the Indigo products, they also heard consumers say loud and clear that they couldn’t believe the mattress could be cleaned from the inside out. This was a huge benefit for them and something they couldn’t find in any other mattress.

“Our mattresses are designed to be updated rather than replaced. Traditional mattresses are not made to last and get prematurely tossed into landfills, forcing consumers to spend money on a replacement mattress too soon,” said co-founder David Funk. “We’ve created a new breed of mattress that can practically last forever, simply by replacing parts that need refreshing. We like to think Indigo is the last mattress you’ll ever have to buy.”

Safety is paramount to the company and they rely upon the latest consumer safety laws and science to place only the cleanest, high-quality, ethically sourced materials into their mattresses, as opposed to potentially harmful, “dirty chemistry” and fiberglass used by many other mattress companies.

Another proprietary advantage of the Indigo design is that the mattress can be opened up to vacuum and deep clean it from the inside out. Mattresses accumulate pounds of dirt and grime over their lifetime, yet until now, there hasn’t been a way to remove the dirt from inside.

“Most people take their mattress for granted and are unaware of the health and environmental dangers they may contain or cause,” said co-founder Gene DeRose. “Indigo is putting an end to that. In addition to providing premium quality at a fair price, we want to bring a new focus on the consumer’s right to be better informed about a product’s attention to health, safety, and environmental sustainability. We’re doing all that and more with our products, but also by collaborating with our customers, initially through the charitable donations each mattress purchase triggers.”

Indigo offers two mattress models, the Comfort Always® CLASSIC and the Comfort Always® LUXURY, which are sold direct to consumers at indigosleep.com. Both are available in Youth/Twin, Full, Queen or King size. Mattresses by Indigo begin at $599.00.

When someone buys an Indigo mattress, the company will donate $50 in the buyer’s name to whatever cause they prefer from among the list of nonprofits carefully selected by Indigo because of their alignment with company values. Among organizations featured are the National Resources Defense Council (NRDC), the American Civil Liberties Union (ACLU), the Southern Poverty Law Center, Planned Parenthood and The Smithsonian Institution.

About Indigo Sleep

Indigo Sleep, based in Tampa, Florida, is a sleep products company whose goal is to disrupt the mattress industry by making better, longer lasting products that use only the cleanest, safest ingredients that are environmentally-friendly. Indigo seeks to make people healthier and happier through better sleep and is grounded in values that protect people and the environment. The company’s mattresses are renewable, upgradable, long lasting and sustainable. For more information or to purchase a mattress, visit indigosleep.com.

Innovative PBM Introduces Pharmacogenetics Offering

Benecard PBF Launches BenePrecise to Eliminate Trial and Error in Finding Medications That Work

BeneCard PBF, a leader in providing clinical solutions that address the crisis of rising drug costs, has taken a step toward more efficient, personalized clinical care for members through its BenePrecise Pharmacogenetics program. Pharmacogenetics allows prescribers and pharmacists to understand how medications react differently in the body based on an individual’s metabolism. BenePrecise applies the results of a fast and easy-to-administer pharmacogenetics test to enhance member safety, improve treatment outcomes and prevent wasteful drug spending.

BenePrecise utilizes precision medicine, which evaluates and considers a patient’s metabolism, environment and lifestyle, to develop effective, individualized treatment plans. Through BenePrecise, BeneCard PBF’s pharmacists work with members and their prescribers to coordinate changes in drug therapies, as indicated by pharmacogenetic testing. This ensures that members receive the most clinically appropriate and effective medications. By proactively identifying which drug therapies will not work, or are likely to cause severe adverse reactions, clients and their members can avoid unnecessary risks and expenses.

“We are excited to offer our BenePrecise program,” says Jennifer Fuhrmann, PharmD and Vice President of Clinical Services for BeneCard PBF. “Pharmacogenetic testing can have a measurable positive impact for members who live with chronic health challenges such as diabetes or high cholesterol. Our pharmacists can help them move quickly onto the most appropriate drug therapy and improve their health with fewer side effects and less risk, based on their unique metabolism.”

There are no doctor’s visits required to administer the test. Members can collect and submit the sample from home using a simple cheek swab. The markers identified by pharmacogenetic testing do not change over a member’s lifetime, so repeat tests are not required.

BenePrecise enables a personalized approach to care aimed at reducing costs, improving treatment efficacy and preventing adverse drug reactions.

About BeneCard PBF

Through pharmacogenetics and proactive clinical programs, BeneCard PBF enhances patient outcomes while lowering prescription drug costs. With offices in Florida, Pennsylvania and New Jersey, BeneCard PBF administers fixed-rate and self-funded prescription benefit programs. The company offers innovative solutions to control costs while providing the highest quality service available in prescription benefit management.

Dynarex Launches Line of Products For Emergency Medical Services (EMS) Industry

Dynarex, a leading medical supply company and provider of disposable medical products, has launched an extensive line of products, specifically for Emergency Medical Services (EMS) professionals and units.

Emergency Medical Services (EMS) exist to fulfill the basic principles of first aid, which are to Preserve Life, Prevent Further Injury and Promote Recovery.  Dynarex strives to help first responders succeed at their jobs, respond to situations at hand and assist the individual or individuals who may be at risk.  Whether they are responding to a 911 call, the first to arrive on an emergency scene or providing medical care in transit, Dynarex is dedicated to offering the most appropriate and needed products.

“Dynarex is committed to serving many market segments within the medical field and beyond.  We are especially committed to EMS professionals and departments, as they are often the first on the scene and they have the most need for our medical products,” said Zalman Tenenbaum, President and CEO of Dynarex.  “Dynarex’s motto is, “We Care Like Family” and we truly consider the EMS community a part of our family because of the important and essential work that they do.”

The products within Dynarex’s new line include:

  • Quick-Release Reusable Tourniquets
  • Compressed Krinkle Gauze
  • Emergency High Strength Pressure Bandages
  • Hemostat Gauze Dressing
  • Disposable Head Loggs
  • Disposable Foam Head Blocks
  • Head Immobilizers
  • Seatbelt Cutters

For information on Dynarex’s complete line of EMS products, visit dynarex.com.

To further validate Dynarex’s commitment to the EMS community, the company is launching the 2017 Dynarex “First Responder Caring Award.”  Dynarex will be recognizing a first responder or department who in recent months has demonstrated the essence of caring or compassion, which can include personnel in EMT, EMS, paramedic, police or fire.  As a result, the company wants to hear from the first responder community with unique and newsworthy stories of heroism, exceptional community service, acts of compassion or demonstration of caring and commitment to others.  Dynarex will award $5,000 in medical supplies to the national winner and $1,000 to each of the four regional semi-finalists, which can be donated by the honoree to their unit or to a worthy 501c3 nonprofit of their choice.  Details on the award can be found here:

About Dynarex

Dynarex is a leading provider of disposable medical products with distributor partners in all 50 states, as well as Canada, Europe and South America. It provides a wide range of the finest quality disposable medical products at an exceptional value while improving suppliers’ processes to increase partners’ profits. The company’s value statement “we care like family” underscores its belief in philanthropy and giving back to partner communities. Founded in 1967, Dynarex is headquartered in Orangeburg, NY. For more information, call 1-888-DYNAREX (1-888-396-2739) or visit dynarex.com.